Zeng Tu

546 total citations
28 papers, 351 citations indexed

About

Zeng Tu is a scholar working on Epidemiology, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Zeng Tu has authored 28 papers receiving a total of 351 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 8 papers in Molecular Biology and 7 papers in Infectious Diseases. Recurrent topics in Zeng Tu's work include Hepatitis B Virus Studies (7 papers), Hepatitis C virus research (7 papers) and RNA regulation and disease (3 papers). Zeng Tu is often cited by papers focused on Hepatitis B Virus Studies (7 papers), Hepatitis C virus research (7 papers) and RNA regulation and disease (3 papers). Zeng Tu collaborates with scholars based in China, United Kingdom and United States. Zeng Tu's co-authors include Ailong Huang, Jieli Hu, Zhijun Bai, Jinhua Liu, Licheng Liu, Meiyu Fang, Yuan Hu, John E. Tavis, Weili Wu and Yao Huang and has published in prestigious journals such as PLoS ONE, Applied and Environmental Microbiology and Journal of Virology.

In The Last Decade

Zeng Tu

27 papers receiving 342 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zeng Tu China 13 127 122 89 77 70 28 351
Sayyad Khanizadeh Iran 13 104 0.8× 80 0.7× 74 0.8× 12 0.2× 59 0.8× 32 302
Sylvie Roy Canada 9 189 1.5× 106 0.9× 59 0.7× 20 0.3× 31 0.4× 10 468
Sara Monzón Spain 12 124 1.0× 97 0.8× 152 1.7× 11 0.1× 39 0.6× 31 431
Lijo John India 11 200 1.6× 62 0.5× 114 1.3× 50 0.6× 30 0.4× 22 395
Nicoletta Scheller Germany 10 269 2.1× 55 0.5× 42 0.5× 21 0.3× 61 0.9× 14 378
Katrin Mair Germany 4 246 1.9× 39 0.3× 89 1.0× 17 0.2× 11 0.2× 4 459
Françoise Donnadieu France 8 217 1.7× 58 0.5× 84 0.9× 27 0.4× 9 0.1× 10 380
Vidyanath Chaudhary Hong Kong 11 166 1.3× 107 0.9× 192 2.2× 124 1.6× 21 0.3× 17 516
Noushin Davoudi Iran 10 105 0.8× 170 1.4× 29 0.3× 263 3.4× 20 0.3× 24 408
Elektra Peta Italy 10 165 1.3× 127 1.0× 104 1.2× 76 1.0× 5 0.1× 11 403

Countries citing papers authored by Zeng Tu

Since Specialization
Citations

This map shows the geographic impact of Zeng Tu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zeng Tu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zeng Tu more than expected).

Fields of papers citing papers by Zeng Tu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zeng Tu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zeng Tu. The network helps show where Zeng Tu may publish in the future.

Co-authorship network of co-authors of Zeng Tu

This figure shows the co-authorship network connecting the top 25 collaborators of Zeng Tu. A scholar is included among the top collaborators of Zeng Tu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zeng Tu. Zeng Tu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Zhang, Mengmeng, Guo‐Liang Wang, Xiaoyan Deng, et al.. (2024). Loss of ADAR1 induces ferroptosis of breast cancer cells. Cellular Signalling. 121. 111258–111258. 14 indexed citations
3.
Chen, Shuang, Caihua Li, Zeng Tu, et al.. (2024). Off-label use of Baricitinib improves moderate and severe atopic dermatitis in China through inhibiting MAPK and PI3K/Akt/mTOR pathway via targeting JAK-STAT signaling of CD4+ cells. Frontiers in Pharmacology. 15. 1324892–1324892. 8 indexed citations
4.
Guo, Junming, et al.. (2023). Reduced Survival and Resistance of Rhodotorula mucilaginosa Following Inhibition of Pigment Production by Naftifine. Current Microbiology. 80(9). 285–285. 1 indexed citations
6.
Liu, Qianqian, et al.. (2023). Alleviation of DSS-induced colitis in mice by a new-isolated Lactobacillus acidophilus C4. Frontiers in Microbiology. 14. 1137701–1137701. 14 indexed citations
7.
Liu, Qianqian, et al.. (2023). Anti-inflammatory effect of Lactiplantibacillus plantarum T1 cell-free supernatants through suppression of oxidative stress and NF-κB- and MAPK-signaling pathways. Applied and Environmental Microbiology. 89(10). e0060823–e0060823. 20 indexed citations
8.
Li, Jie, Jinlan Wang, Wenlu Zhang, et al.. (2022). Protein sensors combining both on-and-off model for antibody homogeneous assay. Biosensors and Bioelectronics. 209. 114226–114226. 7 indexed citations
9.
Wang, Siyuan, Tingting Chen, Zeng Tu, et al.. (2022). ADAR1p110 promotes Enterovirus D68 replication through its deaminase domain and inhibition of PKR pathway. Virology Journal. 19(1). 222–222. 2 indexed citations
10.
Wang, Lu, Qianqian Liu, Rui Hao, et al.. (2022). Characterization of a Hyaluronidase-Producing Bacillus sp. CQMU-D Isolated from Soil. Current Microbiology. 79(11). 328–328. 4 indexed citations
11.
Li, Yimin, et al.. (2019). Mixed Infection of Toe Nail Caused by Trichosporon asahii and Rhodotorula mucilaginosa. Mycopathologia. 185(2). 373–376. 13 indexed citations
12.
Guo, Yanan, Lei Xu, Yimin Li, et al.. (2019). The response of hepatitis B virus genotype to interferon is associated with a mutation in the interferon-stimulated response element. Medicine. 98(51). e18442–e18442. 6 indexed citations
13.
Wang, Xin, Wanyan Deng, Haijun Deng, et al.. (2018). Quasispecies characters of hepatitis B virus in immunoprophylaxis failure infants. European Journal of Clinical Microbiology & Infectious Diseases. 37(6). 1153–1162. 12 indexed citations
14.
Chen, Yanmeng, Jie Hu, Yao Huang, et al.. (2017). APOBEC3B edits HBV DNA and inhibits HBV replication during reverse transcription. Antiviral Research. 149. 16–25. 34 indexed citations
15.
Luo, Xuan, Yao Huang, Yanmeng Chen, et al.. (2016). Association of Hepatitis B Virus Covalently Closed Circular DNA and Human APOBEC3B in Hepatitis B Virus-Related Hepatocellular Carcinoma. PLoS ONE. 11(6). e0157708–e0157708. 25 indexed citations
16.
Liu, Yonghong, Yanwen Zhou, Jingyan Yang, et al.. (2014). Gene polymorphisms associated with susceptibility to coronary artery disease in Han Chinese people. Genetics and Molecular Research. 13(2). 2619–2627. 12 indexed citations
17.
Tu, Zeng, Yuan Hu, Lei Xu, et al.. (2014). An improved method for simple and efficient hepatitis B virus genome cloning. Journal of Virological Methods. 205. 75–80. 2 indexed citations
18.
Xu, Lei, Zeng Tu, Yuwei Wang, et al.. (2014). Epirubicin directly promotes hepatitis B virus (HBV) replication in stable HBV-expressing cell lines: A novel mechanism of HBV reactivation following anticancer chemotherapy. Molecular Medicine Reports. 9(4). 1345–1350. 33 indexed citations
19.
Tu, Zeng, et al.. (2013). Mutant spectrum of dengue type 1 virus in the plasma of patients from the 2006 epidemic in South China. International Journal of Infectious Diseases. 17(11). e1080–e1081. 3 indexed citations
20.
Wu, Weili, Zhijun Bai, Zeng Tu, et al.. (2011). Molecular epidemiology of dengue viruses in southern China from 1978 to 2006. Virology Journal. 8(1). 322–322. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026